Core Laboratories (CLB) Competitors

Valaris (NYSE:VAL) and Core Laboratories (NYSE:CLB) are both energy companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.

Which has higher valuation and earnings, VAL or CLB?

Valaris has higher revenue and earnings than Core Laboratories. Valaris is trading at a lower price-to-earnings ratio than Core Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Valaris	$2.36B	1.21	$865.40M	$5.14	7.84
Core Laboratories	$523.85M	1.38	$31.40M	$0.66	23.44

Does the media favor VAL or CLB?

In the previous week, Valaris and Valaris both had 4 articles in the media. Core Laboratories' average media sentiment score of 1.34 beat Valaris' score of 0.53 indicating that Core Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Valaris	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Core Laboratories	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer VAL or CLB?

Valaris presently has a consensus price target of $54.33, suggesting a potential upside of 34.80%. Core Laboratories has a consensus price target of $17.50, suggesting a potential upside of 13.12%. Given Valaris' stronger consensus rating and higher probable upside, equities analysts clearly believe Valaris is more favorable than Core Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Valaris	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Core Laboratories	1 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.75

Is VAL or CLB more profitable?

Valaris has a net margin of 15.81% compared to Core Laboratories' net margin of 5.99%. Valaris' return on equity of 17.40% beat Core Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Valaris	15.81%	17.40%	8.52%
Core Laboratories	5.99%	16.24%	6.82%

Is VAL or CLB a better dividend stock?

Valaris pays an annual dividend of $1.48 per share and has a dividend yield of 3.7%. Core Laboratories pays an annual dividend of $0.04 per share and has a dividend yield of 0.3%. Valaris pays out 28.8% of its earnings in the form of a dividend. Core Laboratories pays out 6.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Does the MarketBeat Community believe in VAL or CLB?

Core Laboratories received 451 more outperform votes than Valaris when rated by MarketBeat users. Likewise, 54.47% of users gave Core Laboratories an outperform vote while only 33.96% of users gave Valaris an outperform vote.

Company	Underperform	Outperform
Valaris	Outperform Votes 18 33.96%	Underperform Votes 35 66.04%
Core Laboratories	Outperform Votes 469 54.47%	Underperform Votes 392 45.53%

Which has more volatility & risk, VAL or CLB?

Valaris has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, Core Laboratories has a beta of 2.38, indicating that its stock price is 138% more volatile than the S&P 500.

Do institutionals and insiders believe in VAL or CLB?

96.7% of Valaris shares are held by institutional investors. Comparatively, 97.8% of Core Laboratories shares are held by institutional investors. 0.1% of Valaris shares are held by company insiders. Comparatively, 0.8% of Core Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Valaris and Core Laboratories tied by winning 9 of the 18 factors compared between the two stocks.